| Reported | Recall | Class | Product | Firm |
|---|
| 2023-03-01 | D-0335-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0336-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0337-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0338-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0339-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0340-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0341-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0342-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0343-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0344-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0345-2023 | Class II | TIROSINT | IBSA PHARMA INC |
| 2023-03-01 | D-0346-2023 | Class II | 0 | B. Braun Medical Inc. |
| 2023-03-01 | D-0347-2023 | Class II | 0 | B. Braun Medical Inc. |
| 2023-03-01 | D-0348-2023 | Class II | Warfarin Sodium Tablets | RISING PHARMACEUTICALS |
| 2023-02-22 | D-0266-2023 | Class II | Thiamine Hydrochloride 200 mg/2mL | McGuff Compounding Pharmacy Services, Inc. |
| 2023-02-22 | D-0267-2023 | Class II | Thiamine Hydrochloride 3000 mg/30 mL | McGuff Compounding Pharmacy Services, Inc. |
| 2023-02-22 | D-0269-2023 | Class II | Metoprolol Succinate Extended-Release Tablets | Amerisource Health Services LLC |
| 2023-02-22 | D-0270-2023 | Class II | New & Improved Blue Gel Anesthetic | HTO Nevada, Inc. |
| 2023-02-22 | D-0271-2023 | Class II | Maximum Zone2 Topical Analgesic | HTO Nevada, Inc. |
| 2023-02-22 | D-0272-2023 | Class II | 0 | Sentara Infusion Services |
| 2023-02-22 | D-0273-2023 | Class II | Amikacin 450MG IN NS 45ML | Sentara Infusion Services |
| 2023-02-22 | D-0274-2023 | Class II | AMPICILLIN 12GM IN NS 600M | Sentara Infusion Services |
| 2023-02-22 | D-0275-2023 | Class II | AMPICILLIN 8GM IN NS 400ML | Sentara Infusion Services |
| 2023-02-22 | D-0276-2023 | Class II | Ampicillin/Sulbactam 3GM IN NS 100ML | Sentara Infusion Services |
| 2023-02-22 | D-0277-2023 | Class II | CASPOFUNGIN 50MG IN NS 100ML | Sentara Infusion Services |
| 2023-02-22 | D-0278-2023 | Class II | CEFAZOLIN | Sentara Infusion Services |
| 2023-02-22 | D-0279-2023 | Class II | CEFAZOLIN 5mg/mL/HEPARIN 100unit/ml 1 | Sentara Infusion Services |
| 2023-02-22 | D-0280-2023 | Class II | CEFEPIME | Sentara Infusion Services |
| 2023-02-22 | D-0281-2023 | Class II | CEFOXITIN | Sentara Infusion Services |
| 2023-02-22 | D-0282-2023 | Class II | CEFTRIAXONE | Sentara Infusion Services |
| 2023-02-22 | D-0283-2023 | Class II | CEFTRIAXONE | Sentara Infusion Services |
| 2023-02-22 | D-0284-2023 | Class II | D5 NS 2300ML | Sentara Infusion Services |
| 2023-02-22 | D-0285-2023 | Class II | D5W1/2NS W/ 77MEQ OF SOD ACETATE 1000ML | Sentara Infusion Services |
| 2023-02-22 | D-0286-2023 | Class II | DAPTOMYCIN | Sentara Infusion Services |
| 2023-02-22 | D-0287-2023 | Class II | DAPTOMYCIN | Sentara Infusion Services |
| 2023-02-22 | D-0288-2023 | Class II | Dextrose 10% 720ML | Sentara Infusion Services |
| 2023-02-22 | D-0289-2023 | Class II | Diphenhydramine 18mg in 3 | Sentara Infusion Services |
| 2023-02-22 | D-0290-2023 | Class II | DOBUTAMINE | Sentara Infusion Services |
| 2023-02-22 | D-0291-2023 | Class II | Ertapenem | Sentara Infusion Services |
| 2023-02-22 | D-0292-2023 | Class II | ETHANOL 70% 0 | Sentara Infusion Services |
| 2023-02-22 | D-0293-2023 | Class II | FLUCONAZOLE 200MG NS 100ML | Sentara Infusion Services |
| 2023-02-22 | D-0294-2023 | Class II | GANCICLOVIR | Sentara Infusion Services |
| 2023-02-22 | D-0295-2023 | Class II | HYDROCORTISONE 9a) 2MG IN NS 0 | Sentara Infusion Services |
| 2023-02-22 | D-0296-2023 | Class II | HYDROMORPHONE | Sentara Infusion Services |
| 2023-02-22 | D-0297-2023 | Class II | IMIPENEM/CILASTATIN 2000MG IN NS 400ML | Sentara Infusion Services |
| 2023-02-22 | D-0298-2023 | Class II | INTRALIPID 18GM | Sentara Infusion Services |
| 2023-02-22 | D-0299-2023 | Class II | KYTRIL 350MCG IN 3 | Sentara Infusion Services |
| 2023-02-22 | D-0300-2023 | Class II | Lactated Ringers packaged in volume of 1000ML | Sentara Infusion Services |
| 2023-02-22 | D-0301-2023 | Class II | Levaquin 750MG IN D5W 150ML | Sentara Infusion Services |
| 2023-02-22 | D-0302-2023 | Class II | LEVOTHYROXINE 25MCG IN NS 1 | Sentara Infusion Services |
| 2023-02-22 | D-0303-2023 | Class II | MEROPENEM | Sentara Infusion Services |
| 2023-02-22 | D-0304-2023 | Class II | METHADONE | Sentara Infusion Services |
| 2023-02-22 | D-0305-2023 | Class II | Methylprednisolone 12MG IN NS 1 | Sentara Infusion Services |
| 2023-02-22 | D-0306-2023 | Class II | METRONIDAZOLE 500MG 100ML | Sentara Infusion Services |
| 2023-02-22 | D-0307-2023 | Class II | Milrinone | Sentara Infusion Services |
| 2023-02-22 | D-0308-2023 | Class II | MORPHINE Sulfate | Sentara Infusion Services |
| 2023-02-22 | D-0309-2023 | Class II | MYCAMINE 100MG IN NS 100ML | Sentara Infusion Services |
| 2023-02-22 | D-0310-2023 | Class II | NAFCILLIN 24GM IN NS 1200ML | Sentara Infusion Services |
| 2023-02-22 | D-0311-2023 | Class II | NALBUPHINE | Sentara Infusion Services |
| 2023-02-22 | D-0312-2023 | Class II | ONDANSETRON 8MG IN NS 100ML | Sentara Infusion Services |
| 2023-02-22 | D-0313-2023 | Class II | PANTOPRAZOLE 30MG IN NS 7 | Sentara Infusion Services |
| 2023-02-22 | D-0314-2023 | Class II | PENICILLIN | Sentara Infusion Services |
| 2023-02-22 | D-0315-2023 | Class II | PIPERACILLIN / TAZOBACTAM | Sentara Infusion Services |
| 2023-02-22 | D-0316-2023 | Class II | Sodium Chloride 0 | Sentara Infusion Services |
| 2023-02-22 | D-0317-2023 | Class II | TOBRAMYCIN 660MG IN NS 66ML | Sentara Infusion Services |
| 2023-02-22 | D-0318-2023 | Class II | TPN | Sentara Infusion Services |
| 2023-02-22 | D-0319-2023 | Class II | TPN 107gm/AA | Sentara Infusion Services |
| 2023-02-22 | D-0320-2023 | Class II | TPN | Sentara Infusion Services |
| 2023-02-22 | D-0321-2023 | Class II | TPN | Sentara Infusion Services |
| 2023-02-22 | D-0322-2023 | Class II | Vancomycin | Sentara Infusion Services |
| 2023-02-22 | D-0323-2023 | Class II | VANCOMYCIN | Sentara Infusion Services |
| 2023-02-22 | D-0324-2023 | Class II | VITAMIN K | Sentara Infusion Services |
| 2023-02-22 | D-0325-2023 | Class II | Techni-Care Chloroxylenold 3% | Consolidated Chemical, Inc |
| 2023-02-22 | D-0326-2023 | Class II | Humatrix Microclysmic Gel | Consolidated Chemical, Inc |
| 2023-02-22 | D-0327-2023 | Class II | Abelcet | Leadiant Biosciences, Inc. |
| 2023-02-22 | D-0328-2023 | Class II | BuPROPion Hydrochloride Tablets | Amerisource Health Services LLC |
| 2023-02-15 | D-0263-2023 | Class II | Ohm Hand Sanitizer | Urban Electric Power |
| 2023-02-15 | D-0264-2023 | Class II | Ohm Sanitizer Spray | Urban Electric Power |
| 2023-02-15 | D-0265-2023 | Class III | Atropine Sulfate Ophthalmic Solution | Akorn, Inc. |
| 2023-02-15 | D-0268-2023 | Class II | Posaconazole Delayed-Release Tablets | BIOCON PHARMA INC |
| 2023-02-08 | D-0244-2023 | Class I | Easy Care first aid Burn Cream | GFA Production Xiamen Co. Ltd. |
| 2023-02-08 | D-0245-2023 | Class I | Adventure Marine 150 | GFA Production Xiamen Co. Ltd. |
| 2023-02-08 | D-0246-2023 | Class I | Adventure First Aid 1 | GFA Production Xiamen Co. Ltd. |
| 2023-02-08 | D-0247-2023 | Class I | Adventure First Aid 1 | GFA Production Xiamen Co. Ltd. |
| 2023-02-08 | D-0248-2023 | Class I | Easy Care First Aid 25 Person 2009 ANSI | GFA Production Xiamen Co. Ltd. |
| 2023-02-08 | D-0249-2023 | Class I | Easy Care First Aid 10 Person 2009 ANSI | GFA Production Xiamen Co. Ltd. |
| 2023-02-08 | D-0250-2023 | Class I | Easy Care First Aid Class A ANSI 25 Person | GFA Production Xiamen Co. Ltd. |
| 2023-02-08 | D-0251-2023 | Class I | Easy Care First Aid 25 Person 2009 ANSI | GFA Production Xiamen Co. Ltd. |
| 2023-02-08 | D-0252-2023 | Class I | CVS First Aid Home | GFA Production Xiamen Co. Ltd. |
| 2023-02-08 | D-0253-2023 | Class I | Easy Care First Aid 10 Person 2009 ANSI | GFA Production Xiamen Co. Ltd. |
| 2023-02-08 | D-0254-2023 | Class II | Easy Clean Antiseptic Hand Sanitizer Solution 65% with Glycerine | Frenda Corporation |
| 2023-02-08 | D-0255-2023 | Class II | Easy Clean Alcohol Mult Surface Disinfecting Cleaner 75% Ethyl Alcohol | Frenda Corporation |
| 2023-02-08 | D-0256-2023 | Class II | Easy Clean Isopropyl Alcohol 99% | Frenda Corporation |
| 2023-02-08 | D-0257-2023 | Class II | Easy Clean 70% Isopropyl Alcohol | Frenda Corporation |
| 2023-02-08 | D-0258-2023 | Class II | Easy Clean 75% Ethyl Alcohol | Frenda Corporation |
| 2023-02-08 | D-0259-2023 | Class II | Global Care Antibacterial Hand Sanitizer Alcohol Etilico 70% Original | Frenda Corporation |
| 2023-02-08 | D-0260-2023 | Class II | Global Care 70% Alcohol Ethyl Rubbing Alcohol | Frenda Corporation |
| 2023-02-08 | D-0261-2023 | Class II | Conzerol zero molluscum contagiosum | DISCOVERY PHARMA LLC |
| 2023-02-08 | D-0262-2023 | Class II | Diltiazem Hydrochloride Extended-Release Capsules | SUN PHARMACEUTICAL INDUSTRIES INC |
| 2023-02-01 | D-0168-2023 | Class II | Allopurinol Tablets USP | Accord Healthcare, Inc. |
| 2023-02-01 | D-0169-2023 | Class II | Metoprolol Succinate Extended-Release Tablets | Ascend Laboratories, LLC |
| 2023-02-01 | D-0170-2023 | Class II | Metoprolol Succinate Extended-Release Tablets | Ascend Laboratories, LLC |
| 2023-02-01 | D-0171-2023 | Class II | Metoprolol Succinate Extended-Release Tablets | Ascend Laboratories, LLC |
| 2023-02-01 | D-0172-2023 | Class III | FentaNYL Citrate 2 | OurPharma LLC |
| 2023-02-01 | D-0173-2023 | Class II | Allopurinol Tablets 100mg | Preferred Pharmaceuticals, Inc. |
| 2023-02-01 | D-0174-2023 | Class III | Clobetasol propionate Cream USP | Lupin Pharmaceuticals Inc. |
| 2023-02-01 | D-0175-2023 | Class II | Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator | Nephron Sc Inc |
| 2023-02-01 | D-0176-2023 | Class II | S2 Racepinephrine Inhalation Solution | Nephron Sc Inc |
| 2023-02-01 | D-0177-2023 | Class II | 0 | Nephron Sc Inc |
| 2023-02-01 | D-0178-2023 | Class II | Sterile Water for Injection | Nephron Sc Inc |
| 2023-02-01 | D-0179-2023 | Class I | Epinephrine | Spectrum Laboratory Products, Inc. |
| 2023-02-01 | D-0180-2023 | Class I | Epinephrine | Spectrum Laboratory Products, Inc. |
| 2023-02-01 | D-0181-2023 | Class I | Advil | Glaxosmithkline Consumer Healthcare Holdings DBA Haleon |
| 2023-02-01 | D-0182-2023 | Class I | Advil Liqui Gels | Glaxosmithkline Consumer Healthcare Holdings DBA Haleon |
| 2023-02-01 | D-0183-2023 | Class I | Advil Liqui Gels | Glaxosmithkline Consumer Healthcare Holdings DBA Haleon |
| 2023-02-01 | D-0184-2023 | Class I | Vancomycin Hydrochloride for Injection | Pfizer Inc. |
| 2023-02-01 | D-0185-2023 | Class II | Dutasteride 0 | Pharmacy Innovations |
| 2023-02-01 | D-0186-2023 | Class II | Chlorpheniramine/Hyoscyamine | Pharmacy Innovations |
| 2023-02-01 | D-0187-2023 | Class II | Hydroxocobalamin 25MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0188-2023 | Class II | Methylcobalamin 1MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0189-2023 | Class II | Minoxidil 0 | Pharmacy Innovations |
| 2023-02-01 | D-0190-2023 | Class II | 5-Fluorouracil 1% | Pharmacy Innovations |
| 2023-02-01 | D-0191-2023 | Class II | Acetylcysteine 10% Ophthalmic Solution | Pharmacy Innovations |
| 2023-02-01 | D-0192-2023 | Class II | Albuterol | Pharmacy Innovations |
| 2023-02-01 | D-0193-2023 | Class II | Apomorphine HCL 2MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0194-2023 | Class II | Atropine sulfate 0 | Pharmacy Innovations |
| 2023-02-01 | D-0195-2023 | Class II | BSS Plus/Lidocaine Opth 1% | Pharmacy Innovations |
| 2023-02-01 | D-0196-2023 | Class II | Buprenorphine HCL 0 | Pharmacy Innovations |
| 2023-02-01 | D-0197-2023 | Class II | Ceftazidime Intravitreal | Pharmacy Innovations |
| 2023-02-01 | D-0198-2023 | Class II | Cholecalciferol | Pharmacy Innovations |
| 2023-02-01 | D-0199-2023 | Class II | Clindamycin/EDTA Calcium 4 | Pharmacy Innovations |
| 2023-02-01 | D-0200-2023 | Class II | Cyclosporine | Pharmacy Innovations |
| 2023-02-01 | D-0201-2023 | Class II | DEXAMETHASONE 16MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0202-2023 | Class II | Dexpanthenol/Pyridoxine/Hydroxocobalamin-PF- 250MG/100MG/1MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0203-2023 | Class II | Edetate Calcium Disodium 400MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0204-2023 | Class II | EDETATE DISODIUM | Pharmacy Innovations |
| 2023-02-01 | D-0205-2023 | Class II | Estradiol 0 | Pharmacy Innovations |
| 2023-02-01 | D-0206-2023 | Class II | ESTRADIOL CYP/TEST CYP- SS OIL- 2MG/50MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0207-2023 | Class II | Ethyl Alcohol 95% | Pharmacy Innovations |
| 2023-02-01 | D-0208-2023 | Class II | FLURBIPROFEN -CORN OIL- 0 | Pharmacy Innovations |
| 2023-02-01 | D-0209-2023 | Class II | GENTAMICIN BLADDER 0 | Pharmacy Innovations |
| 2023-02-01 | D-0210-2023 | Class II | GLUTATHIONE L REDUCED 100MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0211-2023 | Class II | GLYCERIN 72% | Pharmacy Innovations |
| 2023-02-01 | D-0212-2023 | Class II | GLYCERIN STERILE 99% 2ML VIAL and 5ML VIAL | Pharmacy Innovations |
| 2023-02-01 | D-0213-2023 | Class II | GLYCERIN/LIDOCAINE HCL/EPINEPHRINE 31% | Pharmacy Innovations |
| 2023-02-01 | D-0214-2023 | Class II | HEPARIN/LIDO HCL/SODIUM BICARB 100U/2MG/16 | Pharmacy Innovations |
| 2023-02-01 | D-0215-2023 | Class II | HYDROXOCOBALAMIN-PF- 1MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0216-2023 | Class II | KETAMINE 50MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0217-2023 | Class II | LEVEMIR-STS- 100U/ML | Pharmacy Innovations |
| 2023-02-01 | D-0218-2023 | Class II | LIDOCAINE-PF- 5% | Pharmacy Innovations |
| 2023-02-01 | D-0219-2023 | Class II | MAGNESIUM CHLORIDE HEXAHYDRATE-PF- 200MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0220-2023 | Class II | METHION/INOSIT/CHOLINE/CYANOCOBAL 25MG/50MG/50MG/1MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0221-2023 | Class II | METHOTREXATE INTRAVITREAL | Pharmacy Innovations |
| 2023-02-01 | D-0222-2023 | Class II | METHYLCOBALAMIN 12 | Pharmacy Innovations |
| 2023-02-01 | D-0223-2023 | Class II | MITOMYCIN 0 | Pharmacy Innovations |
| 2023-02-01 | D-0224-2023 | Class II | MITOMYCIN 0 | Pharmacy Innovations |
| 2023-02-01 | D-0225-2023 | Class II | NADH 10MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0226-2023 | Class II | PAPAVERINE/PHENTOLAMINE 30MG/0 | Pharmacy Innovations |
| 2023-02-01 | D-0227-2023 | Class II | PE1/PAPAV/ATROP/CHLOPROM** 7MCG/8 | Pharmacy Innovations |
| 2023-02-01 | D-0228-2023 | Class II | PE1/PAPAV/PHEN 20MCG/30MG/2MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0229-2023 | Class II | PHENOL 10% | Pharmacy Innovations |
| 2023-02-01 | D-0230-2023 | Class II | PHOSPHATIDYLCHOLINE/DEOXYCHOLIC ACID | Pharmacy Innovations |
| 2023-02-01 | D-0231-2023 | Class II | POLIDOCANOL 50MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0232-2023 | Class II | POLYHEXAMETHYLENE BIGUANIDE 0 | Pharmacy Innovations |
| 2023-02-01 | D-0233-2023 | Class II | PROGESTERONE-GS OIL- 100MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0234-2023 | Class II | PROSTAGLANDIN | Pharmacy Innovations |
| 2023-02-01 | D-0235-2023 | Class II | SCOPOLAMINE HYDROBROMIDE 0 | Pharmacy Innovations |
| 2023-02-01 | D-0236-2023 | Class II | SEMAGLUTIDE 0 | Pharmacy Innovations |
| 2023-02-01 | D-0237-2023 | Class II | TACROLIMUS 0 | Pharmacy Innovations |
| 2023-02-01 | D-0238-2023 | Class II | TESTOSTERONE 3% | Pharmacy Innovations |
| 2023-02-01 | D-0239-2023 | Class II | THIAMINE/RIBOFLA/NIACINAMI/DEXPANTH/PYRIDOX/HYDROXYCOBAL… | Pharmacy Innovations |
| 2023-02-01 | D-0240-2023 | Class II | TOBRAMYCIN FORTIFIED 15MG/ML OPH SOLUTION | Pharmacy Innovations |
| 2023-02-01 | D-0241-2023 | Class II | VANCOMYCIN FORTIFIED 10MG/ML | Pharmacy Innovations |
| 2023-02-01 | D-0242-2023 | Class II | VITAMIN D3-AQUEOUS- 10 | Pharmacy Innovations |
| 2023-02-01 | D-0243-2023 | Class II | VORICONAZOLE 10MG/ML | Pharmacy Innovations |
| 2023-01-25 | D-0127-2023 | Class II | Sensorcaine | Fresenius Kabi USA, LLC |
| 2023-01-25 | D-0128-2023 | Class II | Sensorcaine | Fresenius Kabi USA, LLC |
| 2023-01-25 | D-0129-2023 | Class II | Sensorcaine-MPF | Fresenius Kabi USA, LLC |
| 2023-01-25 | D-0131-2023 | Class I | Daptomycin for Injection 350 mg/vial 1 Single-dose vial | Accord Healthcare, Inc. |
| 2023-01-25 | D-0132-2023 | Class II | AK-POLY-BAC brand of Bacitracin cand Polymixin B Sulfate Ophthalmic… | Akorn, Inc. |
| 2023-01-25 | D-0133-2023 | Class II | Artificial Tears OINTMENT | Akorn, Inc. |
| 2023-01-25 | D-0134-2023 | Class II | Artificial Tears Solution | Akorn, Inc. |
| 2023-01-25 | D-0135-2023 | Class II | Betaxolol Ophthalmic Solution | Akorn, Inc. |
| 2023-01-25 | D-0136-2023 | Class II | Ciprofloxacin Ophthalmic Solution | Akorn, Inc. |
| 2023-01-25 | D-0137-2023 | Class II | Cromolyn Sodium Ophthalmic Solution | Akorn, Inc. |
| 2023-01-25 | D-0138-2023 | Class II | ERYTHROMYCIN OPHTHALMIC OINTMENT USP 0 | Akorn, Inc. |
| 2023-01-25 | D-0139-2023 | Class II | Erythromycin Ophthalmic Ointment USP | Akorn, Inc. |
| 2023-01-25 | D-0140-2023 | Class II | GONAK Hypromellose Ophthalmic Demulcent Solution | Akorn, Inc. |
| 2023-01-25 | D-0141-2023 | Class II | Ketorolac Tromethamine Ophthalmic Solution | Akorn, Inc. |
| 2023-01-25 | D-0142-2023 | Class II | Levofloxacin Ophthalmic Solution 0 | Akorn, Inc. |
| 2023-01-25 | D-0143-2023 | Class II | Lidocaine Hydrochloride Jelly USP | Akorn, Inc. |
| 2023-01-25 | D-0144-2023 | Class II | Moxifloxacin Ophthalmic Solution | Akorn, Inc. |
| 2023-01-25 | D-0145-2023 | Class II | Neomycin and Polymyxin B Sulfates | Akorn, Inc. |
| 2023-01-25 | D-0146-2023 | Class II | Ofloxacin Ophthalmic Solution | Akorn, Inc. |
| 2023-01-25 | D-0147-2023 | Class II | Olopatadine HCl Ophthalmic Solution | Akorn, Inc. |
| 2023-01-25 | D-0148-2023 | Class II | Olopatadine HCL Ophthalmic Solution | Akorn, Inc. |
| 2023-01-25 | D-0149-2023 | Class II | Olopatadine HCl Ophthalmic Solution | Akorn, Inc. |
| 2023-01-25 | D-0150-2023 | Class II | Olopatadine HCl Ophthalmic Solution | Akorn, Inc. |
| 2023-01-25 | D-0151-2023 | Class II | Olopatadine HCl Ophthalmic Solution | Akorn, Inc. |
| 2023-01-25 | D-0152-2023 | Class II | PAREMYD | Akorn, Inc. |